Quest Diagnostics to Double U.S. Coronavirus Testing Capacity by Mid-May

One of the country's largest clinical laboratory operators, Quest Diagnostics (NYSE: DGX) says that by mid-May, it will have enough capacity in the U.S. to perform over 200,000 COVID-19 antibody tests per day. Management made that forecast during Wednesday's otherwise depressing first-quarter earnings call.